Barclays’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
22
-4,350
| -99% | – | ﹤0.01% | 4523 |
|
|
2025
Q1 | $43K | Sell |
4,372
-1,278
| -23% | -$12.6K | ﹤0.01% | 3928 |
|
|
2024
Q4 | $71K | Buy |
5,650
+684
| +14% | +$8.6K | ﹤0.01% | 3868 |
|
|
2024
Q3 | $79K | Buy |
4,966
+3,649
| +277% | +$58K | ﹤0.01% | 3803 |
|
|
2024
Q2 | $31K | Sell |
1,317
-10,260
| -89% | -$242K | ﹤0.01% | 3819 |
|
|
2024
Q1 | $831K | Buy |
11,577
+1,768
| +18% | +$127K | ﹤0.01% | 2537 |
|
|
2023
Q4 | $1.95M | Buy |
9,809
+3,103
| +46% | +$617K | ﹤0.01% | 2175 |
|
|
2023
Q3 | $892K | Sell |
6,706
-1,349
| -17% | -$179K | ﹤0.01% | 2169 |
|
|
2023
Q2 | $1.21M | Buy |
8,055
+1,801
| +29% | +$269K | ﹤0.01% | 2038 |
|
|
2023
Q1 | $917K | Sell |
6,254
-3,703
| -37% | -$543K | ﹤0.01% | 2192 |
|
|
2022
Q4 | $1.58M | Buy |
9,957
+4,329
| +77% | +$686K | ﹤0.01% | 1782 |
|
|
2022
Q3 | $1.08M | Buy |
5,628
+5,299
| +1,611% | +$1.02M | ﹤0.01% | 2065 |
|
|
2022
Q2 | $48K | Sell |
329
-2,967
| -90% | -$433K | ﹤0.01% | 3743 |
|
|
2022
Q1 | $580K | Buy |
+3,296
| New | +$580K | ﹤0.01% | 2701 |
|